Penicillin
G Aqueous (Pfizerpen)
|
Category:
Description:
Indications:
-
Meningococcal
menigitis/septicemia
-
Actinomycosis
-
Clostridial
infections (botulism, gas gangrene and tetanus)
-
Fusopirochetal
infections
-
Rat-bite
fever
-
Listeria
infections
-
Pasteurella
infections
-
Erysipeloid
endocarditis
-
Diphtheria
(adjunct to antitoxin to prevent carrier state)
-
Anthrax
-
Serious
streptococcal infections
-
Syphilis
(neurosyphilis)
-
Disseminated
gonococcal infections
-
Lyme
disease (non-FDA approved indication)
Contraindications:
Precautions:
-
Pregnancy
category B
-
Use
with caution in patients with penicillin or cephalosporin allergy
(5-10% chance of cross-reactivity)
-
Counsel
patient to finish all medication to prevent development of resistance
-
Intramuscular
injection or continuous IV infusion are preferred routes of
administration
-
Dosage
modifications are generally only required in patients with severe
renal impairment
Adverse
Reactions (Side Effects):
|
Dosage:
Administered
by injection (available in powder for injection and premixed/frozen)
-
Meningococcal
menigitis/septicemia:
-
Adult:
24 million units per day (1-2 million units q2h)
-
Adult:
200,000-300,000 units/kg/day q2-4h in divided doses for 24 doses
total
-
Children:
250,000 units/kg/day divided equally q4h for 7-14 days
-
Actinomycosis:
-
Clostridial
infections
-
Fusopirochetal
infections
-
Rat-bite
fever
-
Adult:
12-20 million units/day q4-6h for 3-4 weeks
-
Children:
150,000-250,000 units/kg/day divided equally q4h for 4 weeks
-
Listeria
infections
-
Pasteurella
infections
-
Erysipeloid
endocarditis
-
Diphtheria
-
Adult:
2-3 million units/day q4-6h for 10-12 days
-
Children:
150,000-250,000 units/kg/day divided equally q6h for 7-10 days
-
Anthrax
-
Serious
streptococcal infections
-
Syphilis
-
Disseminated
gonococcal infections
-
Lyme
disease
-
use
oral penicllin V for erythema chronicum migrans
-
200,000-300,000
units/kg/day IV for 10-14 days
|
Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington,
D.C., 20372-5300
|